Your browser doesn't support javascript.
loading
3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine.
Wang, Qian; Barry, Meagan A; Seid, Christopher A; Hudspeth, Elissa M; McAtee, C Patrick; Heffernan, Michael J.
Affiliation
  • Wang Q; Department of Pediatrics (Section of Tropical Medicine), National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas.
  • Barry MA; Texas Children's Hospital Center for Vaccine Development, Houston, Texas.
  • Seid CA; Department of Pediatrics (Section of Tropical Medicine), National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas.
  • Hudspeth EM; Texas Children's Hospital Center for Vaccine Development, Houston, Texas.
  • McAtee CP; Department of Pediatrics (Section of Tropical Medicine), National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas.
  • Heffernan MJ; Texas Children's Hospital Center for Vaccine Development, Houston, Texas.
J Biomed Mater Res B Appl Biomater ; 106(4): 1587-1594, 2018 05.
Article in En | MEDLINE | ID: mdl-28804955

Full text: 1 Database: MEDLINE Main subject: Stearic Acids / Leishmania donovani / Protozoan Proteins / Leishmaniasis Vaccines / Polylactic Acid-Polyglycolic Acid Copolymer / Heterocyclic Compounds, 3-Ring / Leishmaniasis, Visceral / Antigens, Protozoan Language: En Journal: J Biomed Mater Res B Appl Biomater Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Stearic Acids / Leishmania donovani / Protozoan Proteins / Leishmaniasis Vaccines / Polylactic Acid-Polyglycolic Acid Copolymer / Heterocyclic Compounds, 3-Ring / Leishmaniasis, Visceral / Antigens, Protozoan Language: En Journal: J Biomed Mater Res B Appl Biomater Year: 2018 Type: Article